T1	Participants 307 360	postmenopausal women with node negative breast cancer
T2	Participants 596 683	3,585 women who met the study criteria with respect to age, stage, and previous therapy
T3	Participants 488 521	population-based cancer registry,
T4	Participants 1192 1223	140 women were entered on study
T5	Participants 1250 1285	population-based cancer registry il
